Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brief Chemo-Rituximab and Maintenance Rituximab in Elderly DLBCL
NCT00193479Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Apr 2003
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by SCRI Development Innovations. Started Apr 2003; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00193479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193479.